Perrigo (PRGO) EPS (Diluted) (QoQ) (2013 - 2026)
Perrigo (PRGO) EPS (Diluted) (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -61.02% |
| Mar 28, 2026 | -148.21% |
| Dec 31, 2025 | 32.50% |
| Sep 27, 2025 | 34.51% |
| Jun 28, 2025 | -21.10% |
| Mar 29, 2025 | -116.19% |
| Dec 31, 2024 | 11.70% |
| Sep 28, 2024 | -25.56% |
| Jun 29, 2024 | -29.04% |
| Mar 30, 2024 | 55.11% |
| Dec 31, 2023 | -287.87% |
| Sep 30, 2023 | -139.47% |
| Jul 1, 2023 | 74.01% |
| Apr 1, 2023 | 82.78% |
| Dec 31, 2022 | -507.71% |
| Oct 1, 2022 | 1,450.00% |
| Jul 2, 2022 | 81.90% |
| Apr 2, 2022 | 95.13% |
| Dec 31, 2021 | -350.67% |
| Oct 2, 2021 | -109.21% |